Research Article
Tissue Reactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Tumors of Neuroectodermal, Mesodermal, and Epithelial Origin
Table 4
Recognition of 14F7 Mab in primary nervous system tumors of pediatrics patients.
| Histopathological | | | Score | | | 0 | 1 | 2 | 3 | Total (%) |
| Pilocytic astrocytoma | 4 | 0 | 0 | 0 | 0/4 | Diffuse astrocytoma | 2 | 0 | 1 | 2 | 3/5 (60.00) | Anaplastic astrocytoma | 3 | 1 | 1 | 3 | 5/8 (62.50) | Glioblastoma | 0 | 0 | 0 | 2 | 2/2 | Oligodendroglioma | 0 | 1 | 0 | 0 | 1/1 | Ependymoma | 1 | 0 | 0 | 0 | 0/1 | Anaplastic ependymoma | 4 | 0 | 1 | 0 | 1/5 (20.00) | Medulloblastoma | 2 | 0 | 0 | 0 | 0/2 | Neuroblastoma | 1 | 0 | 0 | 2 | 2/3 (66.66) | Ganglioneuroblastoma | 0 | 0 | 2 | 0 | 2/2 | Ependymoblastoma | 2 | 0 | 0 | 0 | 0/2 |
|
|
grade classification. 0: no staining; 1: weak staining; 2: moderate staining; 3: strong staining of malignant cells.
|